Sexual function in patients with testicular neoplasm before specialized treatment methods. Clinical trial
Open Access
- 4 July 2024
- journal article
- Published by "MedINK" Publishing House in Andrology and Genital Surgery
- Vol. 25 (2) , 110-119
Abstract
Introduction. Testicular neoplasms (TN) are one of the most common oncological diseases among young men. Currently the sexual function of such patients remains understudied. The aim of the study was to assess the state of sexual function in men with testicular neoplasms before treatment. Material and methods. The cross-sectional continuous single-center study included 35 men with TN. The average age of patients was 34.2–8.2 years (95% CI: 31.4-37.1). The comparison group included 28 healthy volunteers, average age 30.5–4.9 years (95% CI: 28.6-32.4). Some social characteristics of the patient (marriage and children), the state of sexual function (using the IIEF-15 and ICF questionnaires), the level of anxiety and depression (according to the HADS scale), the levels of total and free testosterone, globulin-binding sex hormone (SHBG), follicle-stimulating hormone (FSH), luteinizing hormone (LH) and prolactin were evaluated. Results. Patients in the main group showed a decrease in erection in 10 (28.6%), satisfaction with sexual intercourse in 12 (34.3%), impaired orgasmic function in 2 (5.7%), decreased libido and overall satisfaction in 9 (25.7%). Nonparametric analysis revealed a statistically significant decrease in libido (p < 0.05), satisfaction with sexual intercourse (p < 0.05) and overall satisfaction (p = 0.007) in patients of the main group compared with the control group. Patients with testicular neoplasms had disorders of the mental component – in 12 (34.3%), erection – in 20 (57.1%), neurohumoral – in 25 (71.4%), ejaculatory – in 10 (28.6%) patients. Subclinical depression was observed in 13 (37.1%) and clinically pronounced depression in 11 (31.4%) patients of the main group. Anxiety and depression were statistically significantly more common in the main group (p = 0.0013). The level of anxiety and depression was more pronounced in unmarried (p = 0.013) children-free patients (p = 0.025). Low levels of total testosterone were detected in 13 (39.4%), free testosterone in 12 (38.7%), LH in 11 (33.3%), FSH in 6 (18.7%) patients from the main group. Elevated levels of LH were recorded in 4 (12.1%), FSH in 4 (12.5%), prolactin in 2 (6.9%) and SHBG in 1 (5%). Conclusion. Patients with TN have a deterioration in sexual function compared to a healthy population of the same age group. The further studies are needed to access the influence of tumor histology and treatment of sexual function.Keywords
This publication has 21 references indexed in Scilit:
- Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and CisplatinEuropean Urology Focus, 2018
- Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumorMedical Oncology, 2017
- Masculine norms about emotionality and social constraints in young and older adult men with cancerJournal of Behavioral Medicine, 2016
- The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship studyJournal of Cancer Survivorship, 2015
- Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivorsMedical Oncology, 2014
- Health-related quality of life, depression, and sexual function in testicular cancer survivors in a developing country: a Serbian experienceSupportive Care in Cancer, 2012
- The pituitary-Leydig cell axis before and after orchiectomy in patients with stage I testicular cancerEuropean Journal of Cancer, 2011
- Sexual function, depressive symptoms and marital status in nonseminoma testicular cancer patients: a longitudinal studyPsycho-Oncology, 2009
- Is the Sexual Function Compromised in Long-Term Testicular Cancer Survivors?European Urology, 2007
- Quality-of-life issues in the treatment of testicular cancerWorld Journal of Urology, 1999